Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-05-30 Sale |
2025-06-02 8:55 pm |
GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO |
10,000 | $110.42 | $1,104,193 | 620,268 (Direct) |
View |
2025-05-22 Sale |
2025-05-23 3:16 pm |
GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer |
28,000 | $107.52 | $3,010,564 | 379,872 (Direct) |
View |
2025-05-15 Sale |
2025-05-16 4:34 pm |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
2,500 | $99.82 | $249,550 | 165,674 (Direct) |
View |
2025-04-15 Sale |
2025-04-16 3:22 pm |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
2,500 | $106.4 | $266,000 | 168,174 (Direct) |
View |
2025-03-17 Sale |
2025-03-18 4:37 pm |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
2,500 | $110.53 | $276,325 | 170,674 (Direct) |
View |
2025-03-10 Sale |
2025-03-12 6:41 pm |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
17,929 | $118.17 | $2,118,696 | 301,335 (Direct) |
View |
2025-02-18 Purchase |
2025-02-20 7:42 pm |
Arcus Biosciences Inc. | RCUS | GILEAD SCIENCES INC. 10% Owner |
1,363,636 | $11 | $14,999,996 | 31,424,760 (Direct) |
View |
2025-02-18 Sale |
2025-02-19 4:43 pm |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
2,500 | $104.09 | $260,225 | 169,061 (Direct) |
View |
2025-02-12 Sale |
2025-02-13 9:13 pm |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
137,676 | $102.22 | $14,073,241 | 267,667 (Direct) |
View |
2025-01-31 Sale |
2025-02-03 6:09 pm |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
142,180 | $97.22 | $13,822,740 | 234,563 (Direct) |
View |
2025-01-15 Sale |
2025-01-16 3:31 pm |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
2,500 | $91.35 | $228,375 | 129,873 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-06-10 Tax Withholding |
2025-06-11 7:10 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Wilfong Diane E. Interim Corp Controller & CAO |
340 | $110.09 | 54,461 (Direct) |
View |
2025-06-10 Exercise |
2025-06-11 7:10 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Wilfong Diane E. Interim Corp Controller & CAO |
920 | $0 | 54,461 (Direct) |
View |
2025-06-10 Tax Withholding |
2025-06-11 7:01 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC |
430 | $110.09 | 68,190 (Direct) |
View |
2025-06-10 Exercise |
2025-06-11 7:01 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC |
1,313 | $0 | 68,190 (Direct) |
View |
2025-06-10 Tax Withholding |
2025-06-11 6:58 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer |
1,827 | $110.09 | 158,528 (Direct) |
View |
2025-06-10 Exercise |
2025-06-11 6:58 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer |
3,843 | $0 | 158,528 (Direct) |
View |
2025-06-10 Tax Withholding |
2025-06-11 6:55 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO |
4,968 | $110.09 | 734,648 (Direct) |
View |
2025-06-10 Exercise |
2025-06-11 6:55 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO |
10,425 | $0 | 734,648 (Direct) |
View |
2025-06-10 Tax Withholding |
2025-06-11 6:52 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
1,758 | $110.09 | 202,525 (Direct) |
View |
2025-06-10 Exercise |
2025-06-11 6:52 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
3,694 | $0 | 202,525 (Direct) |
View |
2025-05-22 Exercise |
2025-05-23 3:16 pm |
N/A 2029-07-24 |
GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer |
25,000 | $0 | 379,872 (Direct) |
View |
2025-05-22 Exercise |
2025-05-23 3:16 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer |
12,500 | $66.64 | 379,872 (Direct) |
View |
2025-05-07 Option Award |
2025-05-08 8:26 pm |
N/A 2035-05-07 |
GILEAD SCIENCES INC. | GILD | Horning Sandra Director |
8,325 | $0 | 11,956 (Direct) |
View |
2025-05-07 Tax Withholding |
2025-05-08 8:18 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | MANWANI HARISH Director |
296 | $98.9 | 20,902 (Direct) |
View |
2025-05-07 Option Award |
2025-05-08 8:18 pm |
N/A 2035-05-07 |
GILEAD SCIENCES INC. | GILD | MANWANI HARISH Director |
8,325 | $0 | 20,902 (Direct) |
View |
2025-05-07 Option Award |
2025-05-08 8:17 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Kramer Kelly A. Director |
8,325 | $0 | 25,919 (Direct) |
View |
2025-05-07 Option Award |
2025-05-08 8:16 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Bluestone Jeffrey Director |
8,325 | $0 | 12,522 (Direct) |
View |
2025-05-07 Option Award |
2025-05-08 6:27 pm |
N/A 2035-05-07 |
GILEAD SCIENCES INC. | GILD | WELTERS ANTHONY Director |
8,325 | $0 | 18,557 (Direct) |
View |
2025-05-07 Option Award |
2025-05-08 6:25 pm |
N/A 2035-05-07 |
GILEAD SCIENCES INC. | GILD | Rodriguez Javier Director |
8,325 | $0 | 19,027 (Direct) |
View |
2025-05-07 Option Award |
2025-05-08 6:22 pm |
N/A 2035-05-07 |
GILEAD SCIENCES INC. | GILD | LOVE TED W Director |
8,325 | $0 | 11,147 (Direct) |
View |
2025-05-07 Option Award |
2025-05-08 6:20 pm |
N/A 2035-05-07 |
GILEAD SCIENCES INC. | GILD | BARTON JACQUELINE K Director |
8,325 | $0 | 32,865 (Direct) |
View |
2025-04-25 Tax Withholding |
2025-04-28 1:24 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC |
158 | $103.17 | 68,620 (Direct) |
View |
2025-04-25 Exercise |
2025-04-28 1:24 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC |
514 | $0 | 68,620 (Direct) |
View |
Ownership |
2025-03-20 5:42 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Wilfong Diane E. Interim Corp Controller & CAO |
0 | $0 | 78,965 (Direct) |
View |
2025-03-10 Tax Withholding |
2025-03-12 7:15 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer |
3,907 | $117.21 | 240,488 (Direct) |
View |
2025-03-10 Exercise |
2025-03-12 7:15 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer |
8,080 | $0 | 240,488 (Direct) |
View |
2025-03-10 Option Award |
2025-03-12 7:15 pm |
N/A 2035-03-10 |
GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer |
60,110 | $0 | 240,488 (Direct) |
View |
2025-03-10 Tax Withholding |
2025-03-12 7:12 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO |
11,632 | $117.21 | 1,000,259 (Direct) |
View |
2025-03-10 Exercise |
2025-03-12 7:12 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO |
24,024 | $0 | 1,000,259 (Direct) |
View |
2025-03-10 Option Award |
2025-03-12 7:12 pm |
N/A 2035-03-10 |
GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO |
208,085 | $0 | 1,000,259 (Direct) |
View |
2025-03-10 Tax Withholding |
2025-03-12 7:08 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC |
1,130 | $117.21 | 127,074 (Direct) |
View |
2025-03-10 Exercise |
2025-03-12 7:08 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC |
3,343 | $0 | 127,074 (Direct) |
View |
2025-03-10 Option Award |
2025-03-12 7:08 pm |
N/A 2035-03-10 |
GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC |
41,620 | $0 | 127,074 (Direct) |
View |
2025-03-10 Exercise |
2025-03-12 6:41 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
17,929 | $63.91 | 301,335 (Direct) |
View |
2025-03-10 Tax Withholding |
2025-03-12 6:41 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
3,855 | $117.21 | 301,335 (Direct) |
View |
2025-03-10 Exercise |
2025-03-12 6:41 pm |
N/A 2031-03-10 |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
25,897 | $0 | 301,335 (Direct) |
View |
2025-03-10 Option Award |
2025-03-12 6:41 pm |
N/A 2035-03-10 |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
60,110 | $0 | 301,335 (Direct) |
View |
2025-03-10 Tax Withholding |
2025-03-12 6:10 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Patterson Sandra SVP, Controllership |
624 | $117.21 | 49,328 (Direct) |
View |
2025-03-10 Exercise |
2025-03-12 6:10 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Patterson Sandra SVP, Controllership |
1,952 | $0 | 49,328 (Direct) |
View |
2025-03-10 Option Award |
2025-03-12 6:04 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Berger Dietmar Chief Medical Officer |
46,240 | $0 | 95,215 (Direct) |
View |
2025-02-12 Exercise |
2025-02-13 9:13 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
77,691 | $63.91 | 267,667 (Direct) |
View |
2025-02-12 Exercise |
2025-02-13 9:13 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
26,175 | $57.92 | 267,667 (Direct) |
View |
2025-02-12 Exercise |
2025-02-13 9:13 pm |
N/A 2031-03-10 |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
137,676 | $0 | 267,667 (Direct) |
View |
2025-02-12 Exercise |
2025-02-13 9:13 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
18,210 | $83.49 | 267,667 (Direct) |
View |
2025-02-12 Exercise |
2025-02-13 9:13 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
15,600 | $80.72 | 267,667 (Direct) |
View |
2025-02-04 Option Award |
2025-02-06 4:24 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Patterson Sandra SVP, Controllership |
709 | $0 | 37,787 (Direct) |
View |
2025-02-04 Option Award |
2025-02-06 4:21 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC |
12,371 | $0 | 34,011 (Direct) |
View |
2025-02-04 Option Award |
2025-02-06 4:18 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO |
224,504 | $0 | 617,876 (Direct) |
View |
2025-02-04 Tax Withholding |
2025-02-06 4:18 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO |
108,156 | $97.99 | 617,876 (Direct) |
View |
2025-02-04 Option Award |
2025-02-06 4:14 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer |
90,505 | $0 | 119,979 (Direct) |
View |
2025-02-04 Tax Withholding |
2025-02-06 4:14 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer |
45,666 | $97.99 | 119,979 (Direct) |
View |
2025-02-04 Option Award |
2025-02-06 4:11 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
84,488 | $0 | 171,223 (Direct) |
View |
2025-02-04 Tax Withholding |
2025-02-06 4:11 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
43,138 | $97.99 | 171,223 (Direct) |
View |
2025-01-31 Exercise |
2025-02-03 6:09 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
26,170 | $57.92 | 234,563 (Direct) |
View |
2025-01-31 Exercise |
2025-02-03 6:09 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
44,160 | $65.38 | 234,563 (Direct) |
View |
2025-01-31 Exercise |
2025-02-03 6:09 pm |
N/A 2032-03-10 |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
142,180 | $0 | 234,563 (Direct) |
View |
2025-01-31 Exercise |
2025-02-03 6:09 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
71,850 | $72.34 | 234,563 (Direct) |
View |
2025-01-25 Exercise |
2025-01-27 5:47 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC |
515 | $0 | 49,519 (Direct) |
View |
2025-01-25 Tax Withholding |
2025-01-27 5:47 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC |
187 | $93.07 | 49,519 (Direct) |
View |
2025-01-02 Option Award |
2025-01-03 6:38 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Berger Dietmar Chief Medical Officer |
48,975 | $0 | 48,975 (Direct) |
View |